Report Date: 2020

AMR represents a major threat to human health with significant global economic and security implications. In 2015, WHO Member States unanimously approved a Global Plan of Action to tackle AMR. Subsequently, Heads of State endorsed the AMR Action Plan and called for concerted action across all sectors in the context of the One Health approach. This report summarizes not only GLASS activities but also describes developments over the past years in other surveillance programs led by WHO, including resistance to anti-HIV and anti-tuberculosis (TB) medicines, antimalarial drug efficacy and environmental surveillance of AMR.